Neuroreport · 1999 · 61 citations · 3 references
Life SciencesCell BiologyImmunologyApoptosisAutoimmunityNeuroimmunologyApoptosis In Immune CellsApoptosis RegulationApoptotic SignalingCell DeathDeath ReceptorsMultiple SclerosisApoptosis In Autoimmune DiseaseBcl-2 Protein ExpressionFas Ligand-mediated ApoptosisImmune-mediated PathogenesisMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis Pathology
We investigated the sensitivity to cell death of peripheral blood mononuclear cells (PBMCs) from patients with multiple sclerosis (MS). PBMCs from MS patients, following PHA stimulation, were less sensitive to cell death than those from healthy donors (mean +/- s.e.m., 22.5 +/- 1.9 in MS patients vs 36.5 +/- 2.8 in healthy controls; p = 0.0003). However, when Fas-agonist antibody was added, the increase in respect to apoptosis induced by mitogen alone was even higher in MS patients than in controls. In addition, PHA-activated PBMCs from MS patients showed higher surface expression of Fas than controls, while Bcl-2 expression was decreased. This finding raised the question of whether an impaired generation of apoptotic signals may be contributing to the immune component of MS.
3
Increased Fas antigen on T cells in multiple sclerosis
Hisae Ichikawa, Kohei Ota, Makoto Iwata · Journal of Neuroimmunology · 1996 · 60 citations
Life Sciences, Immunology, Neurology +16